Common variation at 10p12.31 near MLLT10 influences meningioma risk
Sara E. Dobbins(Institute of Cancer Research), Richard S. Houlston(Institute of Cancer Research), Roger Henriksson(Umeå University), Minouk J. Schoemaker(Institute of Cancer Research), Michael Kosteljanetz(University of Leeds), Maria Feychting(Karolinska Institutet), Per Hoffmann(Genomics (United Kingdom)), Matthias Simon(University of Bonn), Anthony J. Swerdlow(Institute of Cancer Research), Kenneth Muir(Manchester Academic Health Science Centre), Fay J. Hosking(Institute of Cancer Research), Thomas W. Mühleisen(University of Bonn), P. Yussanne(Institute of Cancer Research), Stefan Lönn(Hallands sjukhus Halmstad), Amy Lloyd(Institute of Cancer Research), Anders Ahlbom(Karolinska Institutet), Peter Broderick(Institute of Cancer Research), Christoffer Johansen(University of Copenhagen), Susanne Moebus(University of Bonn), Bianca Olver(Institute of Cancer Research), Markus M. Nöthen(University of Bonn), Ulrika Andersson(Umeå University), Beatrice Melin(Umeå University), Sarah Hepworth(University of Leeds), Thomas Brännström(Umeå University), Johannes Schramm(University of Bonn), Lewin Eisele(Christian-Albrechts-Universität zu Kiel)
Cited by 55
Related Papers
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
|Nature Genetics|2017|1.1k
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
|Nature Genetics|2012|1k
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
|Nature Genetics|2018|1k
Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery
|New England Journal of Medicine|2017|916
Multiple newly identified loci associated with prostate cancer susceptibility
|Nature Genetics|2008|850